NCT07369453Completed
Exercise to Improve Sleep and Quality of Life in Stroke Patients Receiving Botulinum Toxin Treatment
The Effects of Aerobic Exercise on Sleep Quality, Quality of Life, and Functional Status in Stroke Patients Treated With Botulinum Toxin for Upper Extremity Spasticity
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Brief summary (registry, in English)
This study aimed to investigate the contribution of aerobic exercise programmes to improving sleep quality, quality of life, and functional status, alongside conventional rehabilitation, in stroke patients who had received botulinum toxin treatment for upper extremity spasticity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 23 Dec 2025
- Start date
- 15 Sept 2021
- Primary completion date
- 15 Jan 2024
- Lead sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Diseases
- Stroke
- NCT number
- NCT07369453
What you commit to
- Study type: Interventional
- Participants enrolled: 56
- From 15 Sept 2021 to the primary completion date, 15 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those who had received antispastic or antiepileptic treatment with dose changes in the last month
Other illness
- Stroke patients who had BTX-A injections for lower extremity spasticity or had a Modified Ashworth Scale (MASH) score ≥ 2 for lower extremity spasticity,
- Uncontrolled diabetes, hypertension, cardiovascular diseases,
- Flaccid stroke,
- Upper extremity disorders (fractures, frozen shoulder, arthritis, surgery),
- Pre-existing sleep disorders (obstructive sleep apnea, insomnia, parasomnia, narcolepsy, restless leg syndrome, or psychiatric disorders),
- Cancer diagnosis,
Other
- Cognitive dysfunction,
Who the study is looking for
- 62 patients aged 18-75 years who were planned for botulinum toxin treatment due to upper extremity spasticity following a stroke
Age in the registry: 18 weeks to 75 weeks · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bursa Yuksek Ihtisas Training and Research Hospital Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.